Fundz

Cortexyme, Inc. reported raising $7.6 Million in an initial SEC Form D filing, from an offering of $8 Million

PUBLIC · IRLAFeb 14, 2017$7.6M of $8M raised

Amount Raised

$7.6 Million

$7.6 Million sold, per SEC Form D (first sale Feb 14, 2017)

Round Type

Venture

New HavenBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

IRulya Therapeutics Inc. raised $7.6 Million in a funding round, dated February 14, 2017. IRulya Therapeutics Inc. is based in New Haven, Connecticut, United States.

How much did IRulya Therapeutics Inc. raise?
IRulya Therapeutics Inc. raised $7.6 Million in a funding round on February 14, 2017.
What does IRulya Therapeutics Inc. do?
Cortexyme is developing novel treatments for altering the course of Alzheimer's and other neurological diseases.
Where is IRulya Therapeutics Inc. based and how big is it?
IRulya Therapeutics Inc. is based in New Haven, Connecticut, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as IRulya Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • XTL Biopharmaceuticals Ltd raised $2.8M (Seed) on March 29, 2017.
  • XTL Biopharmaceuticals Ltd raised $2.5M (Seed) on March 1, 2017.
  • AIM ImmunoTech raised $18K (Pre-Seed) on February 13, 2017.
  • Ovid Therapeutics raised $26M on January 20, 2017.
  • Rhythm Pharmaceuticals raised $20M on January 20, 2017.
  • Galectin raised $3M (Seed) on January 6, 2017.

Who to call at IRulya Therapeutics Inc., and when

A new round usually means IRulya Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IRulya Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IRulya Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IRulya Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IRulya Therapeutics Inc.

Location

101 College Street, Suite 210

New Haven, Connecticut, United States

About

Cortexyme is developing novel treatments for altering the course of Alzheimer's and other neurological diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IRulya Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for IRulya Therapeutics Inc.'s next move

See what Strategic adds

IRulya Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.